Additionally, in vitro, antigen-negative Fas receptor-KO (FasKO) melanomas were still susceptible to killing by TCR-activated CD8+ T cells (Extended Data Fig. 5a), suggesting that FasL–Fas interactions are not critical for the tumoricidal mechanism. The gene discussed is FAS; the disease is melanoma.